Champions Oncology, Inc. (FRA:2I3)

Germany · Delayed Price · Currency is EUR

5.70

-0.20 (-3.39%)

At close: Jan 23, 2026

Revenue by Product

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017	Apr '16 Apr 30, 2016	Apr '15 Apr 30, 2015	Apr '14 Apr 30, 2014	Apr '13 Apr 30, 2013	Apr '12 Apr 30, 2012	Apr '11 Apr 30, 2011	Apr '10 Apr 30, 2010	Apr '09 Apr 30, 2009	Apr '08 Apr 30, 2008	Apr '07 Apr 30, 2007	Apr '04 Apr 30, 2004	Apr '03 Apr 30, 2003
Pharmacology Services	48.59M
Pharmacology Services Growth	3.30%
Translational Oncology Solutions Data License	4.68M
Other Translational Oncology Solutions	3.68M
Other Translational Oncology Solutions Growth	18.73%

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017	Apr '16 Apr 30, 2016	Apr '15 Apr 30, 2015	Apr '14 Apr 30, 2014	Apr '13 Apr 30, 2013	Apr '12 Apr 30, 2012	Apr '11 Apr 30, 2011	Apr '10 Apr 30, 2010	Apr '09 Apr 30, 2009	Apr '08 Apr 30, 2008	Apr '07 Apr 30, 2007	Apr '04 Apr 30, 2004	Apr '03 Apr 30, 2003
United States	56.94M
United States Growth	13.54%